5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide

C206H231ClFN37O17 — CID 157452918

IUPAC5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide
SMILESCOc1cc(CCc2n[nH]c(CCc3ccc(O)cc3)c2C(N)=O)ccc1C.Cc1ccc(CCc2[nH]nc(CCc3ccc(O)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2c(C(N)=O)c(CCc3ccc(Cl)cc3)nn2C)cn1.Cc1ccc(CCc2n[nH]c(Cc3ccc(-n4cnc(C)c4)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N4CCOC(=O)C4)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N4CCOCC4)c(F)c3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc([N+](=O)[O-])cc3)c2C(N)=O)cc1.Cc1ccc(CNc2n[nH]c(Cc3ccc(N4CCC(N5CCC(C)CC5)CC4)cc3)c2C(N)=O)cc1
InChIInChI=1S/C30H40N6O.C24H27FN4O2.C24H25N5O.C24H26N4O3.C22H25N3O3.C21H23ClN4O.C21H23N3O2.C20H20N4O3.C20H22N4O/c1-21-3-5-24(6-4-21)20-32-30-28(29(31)37)27(33-34-30)19-23-7-9-25(10-8-23)36-17-13-26(14-18-36)35-15-11-22(2)12-16-35;1-16-2-4-17(5-3-16)6-8-20-23(24(26)30)21(28-27-20)15-18-7-9-22(19(25)14-18)29-10-12-31-13-11-29;1-16-3-5-18(6-4-16)9-12-21-23(24(25)30)22(28-27-21)13-19-7-10-20(11-8-19)29-14-17(2)26-15-29;1-16-2-4-17(5-3-16)8-11-20-23(24(25)30)21(27-26-20)14-18-6-9-19(10-7-18)28-12-13-31-22(29)15-28;1-14-3-4-16(13-20(14)28-2)8-12-19-21(22(23)27)18(24-25-19)11-7-15-5-9-17(26)10-6-15;1-14-3-4-16(13-24-14)8-12-19-20(21(23)27)18(25-26(19)2)11-7-15-5-9-17(22)10-6-15;1-14-2-4-15(5-3-14)8-12-18-20(21(22)26)19(24-23-18)13-9-16-6-10-17(25)11-7-16;1-13-2-4-14(5-3-13)8-11-17-19(20(21)25)18(23-22-17)12-15-6-9-16(10-7-15)24(26)27;1-13-2-4-14(5-3-13)8-11-17-19(20(22)25)18(24-23-17)12-15-6-9-16(21)10-7-15/h3-10,22,26H,11-20H2,1-2H3,(H2,31,37)(H2,32,33,34);2-5,7,9,14H,6,8,10-13,15H2,1H3,(H2,26,30)(H,27,28);3-8,10-11,14-15H,9,12-13H2,1-2H3,(H2,25,30)(H,27,28);2-7,9-10H,8,11-15H2,1H3,(H2,25,30)(H,26,27);3-6,9-10,13,26H,7-8,11-12H2,1-2H3,(H2,23,27)(H,24,25);3-6,9-10,13H,7-8,11-12H2,1-2H3,(H2,23,27);2-7,10-11,25H,8-9,12-13H2,1H3,(H2,22,26)(H,23,24);2-7,9-10H,8,11-12H2,1H3,(H2,21,25)(H,22,23);2-7,9-10H,8,11-12,21H2,1H3,(H2,22,25)(H,23,24)
InChIKeyBSZUYFBNRBNACE-UHFFFAOYSA-N
MW3551.81 g/mol
LogP29.65
Rot. Bonds64

About 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide

5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide (PubChem CID 157452918) has the molecular formula C206H231ClFN37O17 and a molecular weight of 3551.81 g/mol. Its IUPAC name is 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide.

Molecular Properties

Compound Name5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide
PubChem CID157452918
Molecular FormulaC206H231ClFN37O17
Molecular Weight3551.81 g/mol
Exact Mass3548.80
IUPAC Name5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide
SMILESCOc1cc(CCc2n[nH]c(CCc3ccc(O)cc3)c2C(N)=O)ccc1C.Cc1ccc(CCc2[nH]nc(CCc3ccc(O)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2c(C(N)=O)c(CCc3ccc(Cl)cc3)nn2C)cn1.Cc1ccc(CCc2n[nH]c(Cc3ccc(-n4cnc(C)c4)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N4CCOC(=O)C4)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N4CCOCC4)c(F)c3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc([N+](=O)[O-])cc3)c2C(N)=O)cc1.Cc1ccc(CNc2n[nH]c(Cc3ccc(N4CCC(N5CCC(C)CC5)CC4)cc3)c2C(N)=O)cc1
InChIInChI=1S/C30H40N6O.C24H27FN4O2.C24H25N5O.C24H26N4O3.C22H25N3O3.C21H23ClN4O.C21H23N3O2.C20H20N4O3.C20H22N4O/c1-21-3-5-24(6-4-21)20-32-30-28(29(31)37)27(33-34-30)19-23-7-9-25(10-8-23)36-17-13-26(14-18-36)35-15-11-22(2)12-16-35;1-16-2-4-17(5-3-16)6-8-20-23(24(26)30)21(28-27-20)15-18-7-9-22(19(25)14-18)29-10-12-31-13-11-29;1-16-3-5-18(6-4-16)9-12-21-23(24(25)30)22(28-27-21)13-19-7-10-20(11-8-19)29-14-17(2)26-15-29;1-16-2-4-17(5-3-16)8-11-20-23(24(25)30)21(27-26-20)14-18-6-9-19(10-7-18)28-12-13-31-22(29)15-28;1-14-3-4-16(13-20(14)28-2)8-12-19-21(22(23)27)18(24-25-19)11-7-15-5-9-17(26)10-6-15;1-14-3-4-16(13-24-14)8-12-19-20(21(23)27)18(25-26(19)2)11-7-15-5-9-17(22)10-6-15;1-14-2-4-15(5-3-14)8-12-18-20(21(22)26)19(24-23-18)13-9-16-6-10-17(25)11-7-16;1-13-2-4-14(5-3-13)8-11-17-19(20(21)25)18(23-22-17)12-15-6-9-16(10-7-15)24(26)27;1-13-2-4-14(5-3-13)8-11-17-19(20(22)25)18(24-23-17)12-15-6-9-16(21)10-7-15/h3-10,22,26H,11-20H2,1-2H3,(H2,31,37)(H2,32,33,34);2-5,7,9,14H,6,8,10-13,15H2,1H3,(H2,26,30)(H,27,28);3-8,10-11,14-15H,9,12-13H2,1-2H3,(H2,25,30)(H,27,28);2-7,9-10H,8,11-15H2,1H3,(H2,25,30)(H,26,27);3-6,9-10,13,26H,7-8,11-12H2,1-2H3,(H2,23,27)(H,24,25);3-6,9-10,13H,7-8,11-12H2,1-2H3,(H2,23,27);2-7,10-11,25H,8-9,12-13H2,1H3,(H2,22,26)(H,23,24);2-7,9-10H,8,11-12H2,1H3,(H2,21,25)(H,22,23);2-7,9-10H,8,11-12,21H2,1H3,(H2,22,25)(H,23,24)
InChIKeyBSZUYFBNRBNACE-UHFFFAOYSA-N
XLogP29.65
TPSA845.15 Ų
H-Bond Donors21
H-Bond Acceptors36
Rotatable Bonds64
Heavy Atoms262
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003551.81
LogP ≤ 529.65
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'anil_no_alk(40)', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-[[5-chloro-6-(4-propan-2-ylpiperazin-1-yl)-3-pyridinyl]methyl]-3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-1H-pyrazole-4-carboxamide;3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(4-imidazol-1-ylphenyl)methyl]-1H-pyrazole-4-carboxamide;3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(4-methoxyphenyl)methyl]-1H-pyrazole-4-carboxamide;3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(4-phenylphenyl)methyl]-1H-pyrazole-4-carboxamide
CID 158998287
CID 159658319
CID 159658319
5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide
CID 160074853
5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[(3-chlorophenyl)methyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide
CID 161586834

Frequently Asked Questions

What is the IUPAC name of 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide?
The IUPAC name of 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide (CID 157452918) is 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide.
What is the SMILES notation for 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide?
The canonical SMILES for 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide is COc1cc(CCc2n[nH]c(CCc3ccc(O)cc3)c2C(N)=O)ccc1C.Cc1ccc(CCc2[nH]nc(CCc3ccc(O)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2c(C(N)=O)c(CCc3ccc(Cl)cc3)nn2C)cn1.Cc1ccc(CCc2n[nH]c(Cc3ccc(-n4cnc(C)c4)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N4CCOC(=O)C4)cc3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc(N4CCOCC4)c(F)c3)c2C(N)=O)cc1.Cc1ccc(CCc2n[nH]c(Cc3ccc([N+](=O)[O-])cc3)c2C(N)=O)cc1.Cc1ccc(CNc2n[nH]c(Cc3ccc(N4CCC(N5CCC(C)CC5)CC4)cc3)c2C(N)=O)cc1.
What is the InChIKey of 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide?
The InChIKey is BSZUYFBNRBNACE-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H40N6O.C24H27FN4O2.C24H25N5O.C24H26N4O3.C22H25N3O3.C21H23ClN4O.C21H23N3O2.C20H20N4O3.C20H22N4O/c1-21-3-5-24(6-4-21)20-32-30-28(29(31)37)27(33-34-30)19-23-7-9-25(10-8-23)36-17-13-26(14-18-36)35-15-11-22(2)12-16-35;1-16-2-4-17(5-3-16)6-8-20-23(24(26)30)21(28-27-20)15-18-7-9-22(19(25)14-18)29-10-12-31-13-11-29;1-16-3-5-18(6-4-16)9-12-21-23(24(25)30)22(28-27-21)13-19-7-10-20(11-8-19)29-14-17(2)26-15-29;1-16-2-4-17(5-3-16)8-11-20-23(24(25)30)21(27-26-20)14-18-6-9-19(10-7-18)28-12-13-31-22(29)15-28;1-14-3-4-16(13-20(14)28-2)8-12-19-21(22(23)27)18(24-25-19)11-7-15-5-9-17(26)10-6-15;1-14-3-4-16(13-24-14)8-12-19-20(21(23)27)18(25-26(19)2)11-7-15-5-9-17(22)10-6-15;1-14-2-4-15(5-3-14)8-12-18-20(21(22)26)19(24-23-18)13-9-16-6-10-17(25)11-7-16;1-13-2-4-14(5-3-13)8-11-17-19(20(21)25)18(23-22-17)12-15-6-9-16(10-7-15)24(26)27;1-13-2-4-14(5-3-13)8-11-17-19(20(22)25)18(24-23-17)12-15-6-9-16(21)10-7-15/h3-10,22,26H,11-20H2,1-2H3,(H2,31,37)(H2,32,33,34);2-5,7,9,14H,6,8,10-13,15H2,1H3,(H2,26,30)(H,27,28);3-8,10-11,14-15H,9,12-13H2,1-2H3,(H2,25,30)(H,27,28);2-7,9-10H,8,11-15H2,1H3,(H2,25,30)(H,26,27);3-6,9-10,13,26H,7-8,11-12H2,1-2H3,(H2,23,27)(H,24,25);3-6,9-10,13H,7-8,11-12H2,1-2H3,(H2,23,27);2-7,10-11,25H,8-9,12-13H2,1H3,(H2,22,26)(H,23,24);2-7,9-10H,8,11-12H2,1H3,(H2,21,25)(H,22,23);2-7,9-10H,8,11-12,21H2,1H3,(H2,22,25)(H,23,24).
What are the key properties of 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide?
5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide has a molecular weight of 3551.81 g/mol, XLogP of 29.65, 64 rotatable bonds, 21 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(4-aminophenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-chlorophenyl)ethyl]-1-methyl-5-[2-(6-methyl-3-pyridinyl)ethyl]pyrazole-4-carboxamide;5-[(3-fluoro-4-morpholin-4-ylphenyl)methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[2-(4-hydroxyphenyl)ethyl]-3-[2-(3-methoxy-4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-hydroxyphenyl)ethyl]-5-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;5-[[4-(4-methylimidazol-1-yl)phenyl]methyl]-3-[2-(4-methylphenyl)ethyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[(4-nitrophenyl)methyl]-1H-pyrazole-4-carboxamide;3-[2-(4-methylphenyl)ethyl]-5-[[4-(2-oxomorpholin-4-yl)phenyl]methyl]-1H-pyrazole-4-carboxamide;3-[(4-methylphenyl)methylamino]-5-[[4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]phenyl]methyl]-1H-pyrazole-4-carboxamide is sourced from PubChem (CID 157452918), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).